Key Takeaways Alcon's Vision Care unit grew 3% in Q1 2025, driven by contact lens innovation and pricing gains. Alcon might face $80M in added costs from tariffs and pressure from rivals in the competitive eye care space. New launches like SYSTANE PRO PF and Voyager DSLT support ALC's growth and R&D push. Alcon’s (ALC) Vision Care business continues to gain from its diverse portfolio of contact lenses and ocular health products. Additionally, the introduction of new products is poised to help it grow in t ...

Alcon, Inc. (ALC) delivered first-quarter 2025 core earnings per share (EPS) of 73 cents, down 6.4% from the year-ago quarter’s figure. At the constant exchange rate or CER, the figure was in line year over year. However, the metric missed the Zacks Consensus Estimate by 3.9%.Alcon reports “core” results based on non-IFRS (International Financial Reporting Standards) measures. In the first quarter, the company’s EPS was 70 cents, up 40% (50% at CER) year over year.ALC’s Q1 Revenues in DetailNet sales to thi ...